Switch to
More onapp

Jubilant Ingrevia Ltd

JUBLINGREA
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹8,468 cr, stock is ranked 387
Moderate RiskStock is 2.64x as volatile as Nifty
532.001.55 (-0.29%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹8,468 cr, stock is ranked 387
Moderate RiskStock is 2.64x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
17.76
PB RatioPB Ratio
3.48
Dividend YieldDiv. Yield
0.94%
Sector PESector PE
13.62
Sector PBSector PB
2.65
Sector Div YldSctr Div Yld
2.30%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Jubilant Ingrevia Limited is an integrated life science products and solutions provider. The Company offers a broad portfolio of ingredients that find application in a range of industries. Its business is focused on three core segments: Speciality Chemicals, Nutrition and Health Solutions, and Life Science Chemicals. The Speciality Chemicals businesses is organized across four verticals: Speciality Ingredients, Fine Chemicals, Crop Protection Chemicals, and custom development and manufacturing (CDMO). The Nutrition & Health Solutions segment comprises of Nutrition & Health Ingredients, Animal Nutrition & Health Solutions, and Human Nutrition & Health Solutions segments. The Life Science Chemicals is focused on acetyls and alcohol derivatives, which includes products, such as acetic anhydride, ethyl acetate, anhydrous alcohol, acetaldehyde, formaldehyde and propionic anhydride. The Company is focused on serving pharmaceutical, nutrition, agrochemical, consumer and industrial customers.

Investor PresentationView older 

Nov 7, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2020202120220.000.694.98-0.000.050.48
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.21%

See detailed holdings

Recent EventsAll events 

General updates 
Announced OnNov 17, 2022

Jubilant Ingrevia Limited has informed the Exchange about Intimation of Record Date for maturity of Commercial Papers as per the Intimation Letter. | Download

Jubilant Ingrevia Limited has informed the Exchange about Intimation of Record Date for maturity of Commercial Papers as per the Intimation Letter. | Download

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 16, 2022

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be virtually participating in ¬タリCentrum Broking Conference, to be held on Thursday, November 17, 2022. The details of the Investors/Analysts are mentioned in the Intimation Letter. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/Company. | Download

Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be virtually participating in ¬タリCentrum Broking Conference, to be held on Thursday, November 17, 2022. The details of the Investors/Analysts are mentioned in the Intimation Letter. The schedule may undergo change due to exigencies on the part of Investors/ Analysts/Company. | Download

Cash Dividend 
Ex. DateAug 23, 2022

Final • Div/Share: ₹ 2.5

See all events